FR2940064B1 - ANTI-TRANSPARENT AGENT COMPRISING COMPONENTS CAPABLE OF FORMING COVALENT BONDS BETWEEN THEM AND METHOD OF TREATING HUMAN TWO STEP TRANSPIRATION - Google Patents

ANTI-TRANSPARENT AGENT COMPRISING COMPONENTS CAPABLE OF FORMING COVALENT BONDS BETWEEN THEM AND METHOD OF TREATING HUMAN TWO STEP TRANSPIRATION

Info

Publication number
FR2940064B1
FR2940064B1 FR0807295A FR0807295A FR2940064B1 FR 2940064 B1 FR2940064 B1 FR 2940064B1 FR 0807295 A FR0807295 A FR 0807295A FR 0807295 A FR0807295 A FR 0807295A FR 2940064 B1 FR2940064 B1 FR 2940064B1
Authority
FR
France
Prior art keywords
transpiration
covalent bonds
components capable
treating human
forming covalent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0807295A
Other languages
French (fr)
Other versions
FR2940064A1 (en
Inventor
Jean Francois Grollier
Henri Samain
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR0807295A priority Critical patent/FR2940064B1/en
Priority to PCT/EP2009/067647 priority patent/WO2010070139A1/en
Publication of FR2940064A1 publication Critical patent/FR2940064A1/en
Application granted granted Critical
Publication of FR2940064B1 publication Critical patent/FR2940064B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88—Two- or multipart kits
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88—Two- or multipart kits
    • A61K2800/884—Sequential application

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
FR0807295A 2008-12-19 2008-12-19 ANTI-TRANSPARENT AGENT COMPRISING COMPONENTS CAPABLE OF FORMING COVALENT BONDS BETWEEN THEM AND METHOD OF TREATING HUMAN TWO STEP TRANSPIRATION Expired - Fee Related FR2940064B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0807295A FR2940064B1 (en) 2008-12-19 2008-12-19 ANTI-TRANSPARENT AGENT COMPRISING COMPONENTS CAPABLE OF FORMING COVALENT BONDS BETWEEN THEM AND METHOD OF TREATING HUMAN TWO STEP TRANSPIRATION
PCT/EP2009/067647 WO2010070139A1 (en) 2008-12-19 2009-12-21 Antiperspirant comprising components able to form covalent bonds between one another and two-stage method of treatment of sweating in humans

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0807295A FR2940064B1 (en) 2008-12-19 2008-12-19 ANTI-TRANSPARENT AGENT COMPRISING COMPONENTS CAPABLE OF FORMING COVALENT BONDS BETWEEN THEM AND METHOD OF TREATING HUMAN TWO STEP TRANSPIRATION

Publications (2)

Publication Number Publication Date
FR2940064A1 FR2940064A1 (en) 2010-06-25
FR2940064B1 true FR2940064B1 (en) 2011-03-11

Family

ID=41017028

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0807295A Expired - Fee Related FR2940064B1 (en) 2008-12-19 2008-12-19 ANTI-TRANSPARENT AGENT COMPRISING COMPONENTS CAPABLE OF FORMING COVALENT BONDS BETWEEN THEM AND METHOD OF TREATING HUMAN TWO STEP TRANSPIRATION

Country Status (2)

Country Link
FR (1) FR2940064B1 (en)
WO (1) WO2010070139A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2972350B1 (en) * 2011-03-09 2013-09-27 Oreal PROCESS FOR TREATING TRANSPIRATION USING ENCAPSULATED SILICONE COMPOUNDS; COMPOSITIONS CONTAINING THEM
FR2973236B1 (en) * 2011-03-31 2013-12-13 Oreal USE OF A DEVICE FOR TRANSFERRING AN ANTI-TRANSPIRANT COSMETIC FILM APPLIED TO THE SKIN
FR2978036B1 (en) 2011-07-22 2013-07-19 Oreal PROCESS FOR TREATING TRANSPIRATION USING AN ANHYDROUS COMPOSITION COMPRISING TWO REAGENTS PRODUCING IN-SITU ASSEMBLY ON THE SKIN A TRANSPIRING EFFECT
FR2978035B1 (en) 2011-07-22 2015-03-20 Oreal USE AS ANTITRANSPIRANT OF A MULTIVALENT CATION SALT WITHOUT ANTITRANSPIRANT ALUMINUM HALOGEN OR COMPOUND SUSCEPTIBLE TO REACT WITH THIS SALT TO PRODUCE ANTITRANSPIRANT EFFECT
DE102014221673A1 (en) 2014-10-24 2016-04-28 Henkel Ag & Co. Kgaa Chitosan-containing antiperspirant cosmetic agents which are free of halides and / or hydroxy halides of aluminum and / or zirconium

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO149199C (en) * 1977-08-26 1984-03-07 Unilever Nv Antiperspirant PREPARATION.
CA1306954C (en) 1986-04-07 1992-09-01 Yosh Hokama Hard durable nail polish and method of forming
US5456905A (en) 1988-08-23 1995-10-10 Ultraset Limited Partnership Quick-drying nail coating method and composition
FR2760359B1 (en) * 1997-03-04 2000-01-07 Oreal PROCESS FOR TREATING A KERATINIC SUBSTRATE
DE19822791A1 (en) 1998-05-20 1999-11-25 Basf Ag Use of amides of polymerized fatty acids as thickeners
IT1312344B1 (en) 1999-06-03 2002-04-15 Ausimont Spa COMPOSITIONS FOR LOW REFRACTION INDEX FILM.
US6229007B1 (en) 1999-09-30 2001-05-08 Basf Corporation Amine functional cellulose ester compounds and methods of making the same
US6274127B1 (en) 2000-01-27 2001-08-14 The Procter & Gamble Company Anhydrous antiperspirant compositions containing water-reactive monomers as antiperspirant active
US20040156803A1 (en) * 2002-11-29 2004-08-12 Gabin Vic Cosmetic hair treatment process giving the hair long-lasting cosmetic properties
FR2874320B1 (en) * 2004-08-18 2006-10-27 Oreal COSMETIC COMPOSITION COMPRISING AS ANTI - TRYSPIRING AGENT A FLOCCULANT WATER - SOLUBLE POLYMER; PROCESS FOR TREATING TRANSPIRATION
EP1793811A1 (en) 2004-09-07 2007-06-13 Dow Corning Corporation Silicone adhesive formulation containing an antiperspirant
US20070053959A1 (en) 2005-09-02 2007-03-08 Smith Angelina W Anti-perspirant/deodorant peel-on strip

Also Published As

Publication number Publication date
FR2940064A1 (en) 2010-06-25
WO2010070139A1 (en) 2010-06-24

Similar Documents

Publication Publication Date Title
FR2940051B1 (en) MULTI-COMPONENT ANTI-TRANSPIRANT AGENT COMPRISING TWO COMPONENTS CAPABLE OF COOPERATING AND METHOD FOR TREATING HUMAN TRANSPIRATION IN TWO STEPS
ATE523508T1 (en) PYRIDINE AND PYRAZINE DERIVATIVES SUITABLE FOR THE TREATMENT OF CELL PROLIFERATIVE DISEASES
FR2940062B1 (en) MULTI-COMPONENT ANTI-TRANSPIRANT AGENT COMPRISING TWO COMPOUNDS CAPABLE OF REAGIRING BY PHYSICAL INTERACTION AND METHOD OF TREATING TWO-STEP HUMAN TRANSPIRATION
WO2011153477A3 (en) Uses and compositions for treatment of hidradenitis suppurativa (hs)
DOP2014000084A (en) BISPECIFIC IMMUNOLIGANTS DIRECTED AGAINST TNF AND IL-17
FR2940064B1 (en) ANTI-TRANSPARENT AGENT COMPRISING COMPONENTS CAPABLE OF FORMING COVALENT BONDS BETWEEN THEM AND METHOD OF TREATING HUMAN TWO STEP TRANSPIRATION
FR2920968B1 (en) COSMETIC PROCESS FOR AESTHETIC TREATMENT AND / OR REPAIR OF SKIN
CR20110128A (en) METHODS, SYSTEMS AND PRODUCTS TO PREACH THE RESPONSE OF TUMOR CELLS TO A THERAPEUTIC AGENT AND TREAT A PATIENT IN ACCORDANCE WITH THE PREDICTED RESPONSE
BRPI0822162A2 (en) Method for treating nail or nail bed disease and pharmaceutical composition for topical treatment of nail or nail bed disease.
DE112008000881A5 (en) Medical device for the treatment of occlusions of body passages and for the prevention of imminent reocclusions
IL207360A0 (en) Methods of diagnosing and treating parp - mediated diseases
BRPI0712607A8 (en) stroke treatment methods
BRPI0820477A2 (en) Benzodiazepinone compounds useful in the treatment of skin disorders
BRPI0909346A2 (en) granular composition of polyolefin particle-containing tissue treatment, and domestic method of tissue treatment
CO6680695A2 (en) Pharmaceutical formulations containing rifaximin processes for obtaining and method to treat intestinal disease
FR2898603B1 (en) NOVEL POLYURETHANES, COMPOSITIONS COMPRISING THEM AND COSMETIC TREATMENT METHOD
EA201001865A1 (en) ANTI-INFLAMMATORY AGENTS
EP2165715A4 (en) Therapeutic agent for cancer, and method for treatment of cancer
CY1124331T1 (en) INCREASED BIOAVAILABILITY OF ACTIVE SUBSTANCE IN NALTREXONE THERAPY
ATE554396T1 (en) DIAGNOSTIC AND THERAPY TOOLS FOR DISEASES THAT ALTER VASCULAR FUNCTION
EP2240077A4 (en) System and method of cosmetic analysis and treatment diagnosis
BRPI0923534A2 (en) composition and method for treating skin diseases
BR112013011932A2 (en) device for treating premature ejaculation or male organ stimulation
EP2263705A4 (en) Therapeutic agent for nerve injury and method for treating nerve injury
EP2108422A4 (en) Process for treatment of water-containing substance

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 12

ST Notification of lapse

Effective date: 20210806